Telix Pharma to acquire ITM Isotope for $1.65 bln
Australia's Telix Pharmaceuticals has agreed to acquire Germany-based ITM Isotope Technologies Munich SE for about $1.65 billion on a cash- and debt-free basis.
37) apiece, which is supported by Berentzen's supervisory and executive boards.... 65 billion on a cash- and debt-free basis, further boosting its radiopharmaceutical ambitions.... * State-owned China Rare Earth Group is in talks to acquire Shenghe Resources, said two sources with knowledge of the matter, a move that would consolidate Beijing's control over the sector and give the firm a stake in one of Washington's rare earth plays.... com)